Skip to main content
Fig. 3 | BMC Pharmacology and Toxicology

Fig. 3

From: Musculoskeletal adverse events associated with CDK4/6 inhibitors: a real-world study using FDA Adverse Event Reporting System (FAERS) database

Fig. 3

Differences in reporting of 13 representative musculoskeletal adverse events among three different CDK4/6 inhibitors as a radar chart. The signal was normalized to the ROR of bone lesions for Ribociclib as 100%. The highest frequency top-13 PTs with positive signals were selected as the representative musculoskeletal adverse events for the radar chart

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us